Join
ABVC BioPharma Inc. logo

ABVC

NASDAQ

ABVC BioPharma Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical Preparations
$1.32-0.12 (-8.33%)
News25/Ratings0

American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company was incorporated in 2015 and is based in Fremont, California. American BriVision (Holding) Corporation is a subsidiary of YuanGene Corporation.

Price$1.32-0.12 (-8.33%)
2026-03-042026-06-05
News · 26 weeks100%
2025-12-14: 02025-12-21: 02025-12-28: 02026-01-04: 02026-01-11: 12026-01-18: 02026-01-25: 02026-02-01: 12026-02-08: 02026-02-15: 02026-02-22: 02026-03-01: 42026-03-08: 02026-03-15: 02026-03-22: 22026-03-29: 02026-04-05: 02026-04-12: 02026-04-19: 02026-04-26: 02026-05-03: 02026-05-10: 12026-05-17: 12026-05-24: 02026-05-31: 02026-06-07: 0
2025-12-142026-06-07
Mix490d
  • SEC Filings2(50%)
  • Other2(50%)

Latest news

25 items

ABVC FAQ

5 questions
  • What does ABVC BioPharma Inc. do?
    American BriVision (Holding) Corporation, a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, a combination therapy for triple negative breast cancer; ABV-1504 for major depressive disorders; ABV-1505 for attention deficit hyperactivity disorder; ABV-1703 for the treatment of pancreatic cancer; ABV-1702 to treat myelodysplastic syndromes; ABV-1601 for treating depression in cancer patients; and ABV-1701 Vitargus for the treatment of retinal detachment or vitreous hemorrhage. It...
  • Where does ABVC stock trade?
    ABVC BioPharma Inc. (ABVC) is listed on NASDAQ.
  • What sector and industry is ABVC in?
    ABVC BioPharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.
  • What companies are similar to ABVC?
    Notable peers in the same industry include LLY (Eli Lilly and Company), AZN (AstraZeneca PLC), JNJ (Johnson & Johnson), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ABVC side-by-side with any of them on Quantisnow.
  • How can I track ABVC on Quantisnow?
    Quantisnow aggregates ABVC BioPharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ABVC to receive live email and push alerts on every new disclosure.